Badgley, Phelps & Bell’s Avanos Medical AVNS Stock Holding History

Badgley, Phelps & Bell’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$382K	Hold	10,500	–	–	0.01%	173
2021 Q1	$459K	Sell	10,500 -500	-5%	-$23.5K	0.02%	161
2020 Q4	$505K	Hold	11,000	–	–	0.02%	155
2020 Q3	$365K	Sell	11,000 -1,000	-8%	-$32K	0.02%	164
2020 Q2	$353K	Sell	12,000 -2,400	-17%	-$69.5K	0.02%	162
2020 Q1	$388K	Hold	14,400	–	–	0.03%	145
2019 Q4	$485K	Hold	14,400	–	–	0.03%	145
2019 Q3	$539K	Hold	14,400	–	–	0.03%	137
2019 Q2	$628K	Hold	14,400	–	–	0.04%	134
2019 Q1	$615K	Sell	14,400 -600	-4%	-$26.9K	0.04%	136
2018 Q4	$672K	Hold	15,000	–	–	0.05%	124
2018 Q3	$1.03M	Hold	15,000	–	–	0.06%	120
2018 Q2	$859K	Hold	15,000	–	–	0.06%	121
2018 Q1	$691K	Hold	15,000	–	–	0.05%	127
2017 Q4	$693K	Buy	+15,000	New	+$689K	0.05%	128

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Badgley, Phelps & Bell's AVNS Position: Q2 2021 in Review

Badgley, Phelps & Bell held its Avanos Medical (AVNS) position steady in Q2 2021 at 10,500 shares worth $382K. The position accounts for 0.01% of the portfolio, ranked #173.

Badgley, Phelps & Bell first reported a position in AVNS in Q4 2017 and has held it in 15 quarters since. The position peaked at $1.03M in Q3 2018. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2021.

Badgley, Phelps & Bell held 10,500 shares of Avanos Medical worth $382K as of Q2 2021.
Badgley, Phelps & Bell left its Avanos Medical share count unchanged in Q2 2021.
Avanos Medical made up 0.01% of Badgley, Phelps & Bell's portfolio in Q2 2021, its #173 holding.
Badgley, Phelps & Bell first reported a position in Avanos Medical in Q4 2017 and has held it in 15 quarters since.
Badgley, Phelps & Bell's Avanos Medical position peaked at $1.03M in Q3 2018.
274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2021.

Based on Badgley, Phelps & Bell's 13F filing for Q2 2021, filed 28 Jul 2021.